<DOC>
	<DOCNO>NCT02568306</DOCNO>
	<brief_summary>This trial conduct United States America . The aim trial investigate safety , tolerability pharmacokinetics ( exposure trial drug body ) single dose multiple dos NNC0165-1562 overweight obese otherwise healthy subject .</brief_summary>
	<brief_title>A First Human Dose Trial Investigating Safety , Tolerability Pharmacokinetics Single Doses Multiple Doses NNC0165-1562 Overweight Obese But Otherwise Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>Part I ( SD ) : Male , age 1855 year ( inclusive ) time sign informed consent Body mass index ( BMI ) 25.0 34.9 kg/m^2 ( inclusive ) . Overweight due excess adipose tissue , judge investigator Considered generally healthy base medical history , physical examination , result vital sign , electrocardiogram ( ECG ) clinical laboratory test perform screen visit , judge investigator Part II ( MD ) : Male female , age 1855 year ( inclusive ) time sign informed consent Body mass index ( BMI ) 27.0 39.9 kg/m^2 ( inclusive ) . Overweight due excess adipose tissue , judge investigator Considered generally healthy base medical history , physical examination , result vital sign , electrocardiogram ( ECG ) clinical laboratory test perform screen visit , judge investigator Any clinically significant weight change ( least 5 % selfreported change previous 3 month ) , diet attempt ( e.g . participation organise weight reduction programme within last 3 month ) , prior obesity surgery , medication affect body weight within 3 month prior screen Male subject surgically sterilise ( vasectomy ) sexually active female partner ( ) use highly effective method contraception ( condom spermicide ) combine highly effective method contraception nonpregnant female partner ( ) ( Pearl Index 1 % , implant , injectables , oral contraceptive , intrauterine device , diaphragm cervical cap+spermicide ) , and/or intend donate sperm period screen 3 month follow administration investigational medical product Female subject child bear potential ( premenopausal surgically sterilise ) sexually active male partner ( ) surgically sterilise ( vasectomy ) use highly effective contraceptive method ( Pearl Index 1 % , implant , injectables , oral contraceptive , intrauterine device , diaphragm cervical cap+spermicide ) combine highly effective method contraception male partner ( ) ( e.g . condom spermicide ) , and/or pregnant , breastfeed intend become pregnant ) ( applicable Part II ( MD ) )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>